DCB Funding Opportunity and Grants-Related Resources
The NCI Division of Cancer Biology (DCB) provides public resources related to notices of funding opportunities (NOFOs) and NCI grant policies to cancer researchers.
NIH Data Management and Sharing (DMS) Policy Resources
New Grantee Workshop
DCB offers an annual workshop for new and early-stage investigators to familiarize them with the processes and standards of DCB, NCI and NIH. It is designed for DCB grantees who have received their first independent NIH grant within the last year.
It includes breakout sessions with DCB Program Directors and a seminar from an NCI-funded mid-career cancer researcher.
Below is the agenda and the presentations from the January 2024 Workshop (posted with permission from each author; please do not use without consent):
Session 1: The NCI and Your New Investigator Grant
- Introduction to the NIH Grants System and DCB
- NCI Budget and Appropriations
- Communicating with Your NCI Program Director: It's a Two Way Street
- Post-Award Administration of Your NCI Grant
Session 2: Supporting Your Team and Expanding Your Research Enterprise
- Awards to Support Trainees
- Diversity Focused-Training and Cancer Disparities Research Opportunities
- NCI's Commitment to Equity, Diversity, Inclusion, and Anti-Harassment
- Additional Funding Opportunities
- DCB/NCI Resources for Researchers
Session 3: Review, Renew, and Promote Your Science
- Peer Review at NIH
- Review, Resubmission, and Renewals - the Program Perspective
- DCB/NCI Outreach Activities to Promote Science
Questions about the workshop should be directed to Dr. Joanna Watson.
DCB Presentations with Funding and Grants-Related Resources at Meetings
May 30, 2024
American Society for Cell Biology (ASCB) Meet the Funders Webinar with NCI
Slides for the "Funding Opportunities at the NCI Division of Cancer Biology" presentation by Dr. Lillian Kuo.
April 5 - 10, 2024
2024 American Association of Cancer Research (AACR) Meeting
- Slides for the "Overview of NCI Grants Process and Policy Updates" presentation by Dr. Shannon Hughes during the NCI-Selected Session on Review and Funding of Foundational Cancer Biology Research at NIH & NCI.
- Slides for the "Integrating Health Disparities Research into Immuno-Oncology" presentation by Dr. Lillian Kuo during the NCI-Selected Session on Cancer Health Disparities Research Collaborations Across the Center to Reduce Cancer Health Disparities (CRCHD) and DCB.
- Slides for the "Cancer Immunoprevention Network (CIP-Net)" presentation by Dr. Lillian Kuo during the NCI-Selected Session on NCI Funding Opportunities in Cancer Prevention and interception.
- Slides for the "Cancer Immunology Funding Opportunities: Strategies for Early Career Scientists" presentation by Dr. Lillian Kuo during an NCI Meet-the-Expert Talk.
- Slides for the "Investigator-Initiated Grants to Increase the Diversity of Viewpoints in Cancer Research" presentation by Drs. Shannon Hughes and Ruibai Luo during an NCI Meet-the-Expert Talk.
- Slides for the "Cancer Biology Research is Advancing Progress Towards the National Cancer Plan" presentation during an NCI Meet-the-Expert Talk.
- Slides for the "Basic Research in Cancer Health Disparities Funding Opportunities" presentation by Dr. Anu Sharman during an NCI Meet-the-Expert Talk.
- Slides for the "NCI AI Activities and Resources" presentation by Drs. Juli Klemm, Emily Greenspan, Jennifer Couch, and Roxanne Jensen during an NCI Meet-the-Expert Talk.
Pre-application Webinar Materials Related to Funding Opportunities
| NOFO Title(s) | NOFO Number(s) | Webinar Date | Webinar Materials |
|---|---|---|---|
| RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed) | RFA-CA-24-029 | 09/24/2024 | webinar slides and recording |
| Human Tumor Atlas (HTA) Research Centers (U01 Clinical Trial Not Allowed) | RFA-CA-23-039 | 11/09/2023 | webinar slides, recording, and FAQs |
| Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed) & Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed) |
RFA-CA-23-036 & RFA-23-037 | 08/11/2023 | webinar slides, recording, and FAQs |
| Cancer Immunoprevention Network (CIP-Net) Research Projects (UG3/UH3 Clinical Trials Not Allowed) | RFA-CA-23-029 | 05/18/2023 | webinar recording |
|
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
PAR-19-113 & PAR-22-099 | 09/13/2016 | webinar slides |
"Getting a Grant from the NCI" Webinar
On April 21, 2022, Dr. Dan Gallahan (the Director of DCB) was joined by Drs. Joanna Watson (DCB Branch Chief), Amy Rubinstein (Review Branch Chief at the NIH Center for Scientific Review), and Shannon Hughes (DCB Deputy Director) for a special virtual session on NCI grant policies. It covered considerations for new and experienced applicants, as well as information about peer review.
Session Overview
- Introduction: Overview of NIH and NCI (slides)
- Program: Oversight and Grantsmanship (slides)
- Peer Review at NIH (slides)
- Q&A Panel Discussion
Meet the Experts: Getting a Grant from the NCI